Trials / Conditions / B-Lymphocytic Leukemia, Chronic
B-Lymphocytic Leukemia, Chronic
3 registered clinical trials studyying B-Lymphocytic Leukemia, Chronic — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | Anti-CD19 Chimeric Antigen Receptor T-Cell Immunotherapy for Leukemias NCT06364423 | National Cancer Institute (NCI) | Phase 1 / Phase 2 |
| Completed | Ibrutinib, Fludarabine, and Pembrolizumab in High-Risk or Relapsed/Refractory Chronic Lymphocytic Leukemia/Sma NCT03204188 | National Heart, Lung, and Blood Institute (NHLBI) | Phase 2 |
| Terminated | A Phase 1/2 Study To Evaluate ASN002 In Relapsed/Refractory Lymphoma And Advanced Solid Tumors NCT02440685 | Asana BioSciences | Phase 1 / Phase 2 |